Modulating liposomal stealth properties to evade RES and target tumors
Liposomal nanocarriers offer much promise in chemotherapeutic drug delivery because they may be specifically targeted to tumors thereby shielding healthy organs from toxic side effects of incorporated drugs. Passive targeting of liposomes is achieved through the inclusion of PEG to evade the RES an...
| Main Author: | |
|---|---|
| Published: |
Georgia Institute of Technology
2009
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/1853/26650 |